ARIA; CARAT; MASK; asthma; digital transformation of health and care; rhinitis
Abstract :
[en] Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Bousquet, Jean
Anto, Josep M.
Bachert, Claus
Haahtela, Tari
Zuberbier, Torsten
Czarlewski, Wienczyslawa
Bedbrook, Anna
Bosnic-Anticevich, Sinthia
Walter Canonica, G.
Cardona, Victoria
Costa, Elisio
Cruz, Alvaro A.
Erhola, Marina
Fokkens, Wytske J.
Fonseca, Joao A.
Illario, Maddalena
Ivancevich, Juan-Carlos
Jutel, Marek
Klimek, Ludger
Kuna, Piotr
Kvedariene, Violeta
Le, Ltt
Larenas-Linnemann, Désirée E.
Laune, Daniel
Lourenço, Olga M.
Melén, Erik
Mullol, Joaquim
Niedoszytko, Marek
Odemyr, Mikaëla
Okamoto, Yoshitaka
Papadopoulos, Nikos G.
Patella, Vincenzo
Pfaar, Oliver
Pham-Thi, Nhân
Rolland, Christine
Samolinski, Boleslaw
Sheikh, Aziz
Sofiev, Mikhail
Suppli Ulrik, Charlotte
Todo-Bom, Ana
Tomazic, Peter-Valentin
Toppila-Salmi, Sanna
Tsiligianni, Ioanna
Valiulis, Arunas
Valovirta, Erkka
Ventura, Maria-Teresa
Walker, Samantha
Williams, Sian
Yorgancioglu, Arzu
Agache, Ioana
Akdis, Cezmi A.
Almeida, Rute
Ansotegui, Ignacio J.
Annesi-Maesano, Isabella
Arnavielhe, Sylvie
Basagaña, Xavier
D Bateman, Eric
Bédard, Annabelle
Bedolla-Barajas, Martin
Becker, Sven
Bennoor, Kazi S.
Benveniste, Samuel
Bergmann, Karl C.
Bewick, Michael
Bialek, Slawomir
E Billo, Nils
Bindslev-Jensen, Carsten
Bjermer, Leif
Blain, Hubert
Bonini, Matteo
Bonniaud, Philippe
Bosse, Isabelle
Bouchard, Jacques
Boulet, Louis-Philippe
Bourret, Rodolphe
Boussery, Koen
Braido, Fluvio
Briedis, Vitalis
Briggs, Andrew
Brightling, Christopher E.
Brozek, Jan
Brusselle, Guy
Brussino, Luisa
Buhl, Roland
Buonaiuto, Roland
Calderon, Moises A.
Camargos, Paulo
Camuzat, Thierry
Caraballo, Luis
Carriazo, Ana-Maria
Carr, Warner
Cartier, Christine
Casale, Thomas
Cecchi, Lorenzo
Cepeda Sarabia, Alfonso M.
H Chavannes, Niels
Chkhartishvili, Ekaterine
Chu, Derek K.
Cingi, Cemal
Correia de Sousa, Jaime
Costa, David J.
Courbis, Anne-Lise
Custovic, Adnan
Cvetkosvki, Biljana
D'Amato, Gennaro
da Silva, Jane
Dantas, Carina
Dokic, Dejan
Dauvilliers, Yves
De Feo, Giulia
De Vries, Govert
Devillier, Philippe
Di Capua, Stefania
Dray, Gerard
Dubakiene, Ruta
Durham, Stephen R.
Dykewicz, Mark
Ebisawa, Motohiro
Gaga, Mina
El-Gamal, Yehia
Heffler, Enrico
Emuzyte, Regina
Farrell, John
Fauquert, Jean-Luc
Fiocchi, Alessandro
Fink-Wagner, Antje
Fontaine, Jean-François
Fuentes Perez, José M.
Gemicioğlu, Bilun
Gamkrelidze, Amiran
Garcia-Aymerich, Judith
Gevaert, Philippe
Gomez, René Maximiliano
González Diaz, Sandra
Gotua, Maia
Guldemond, Nick A.
Guzmán, Maria-Antonieta
Hajjam, Jawad
Huerta Villalobos, Yunuen R.
Humbert, Marc
Iaccarino, Guido
Ierodiakonou, Despo
Iinuma, Tomohisa
Jassem, Ewa
Joos, Guy
Jung, Ki-Suck
Kaidashev, Igor
Kalayci, Omer
Kardas, Przemyslaw
Keil, Thomas
Khaitov, Musa
Khaltaev, Nikolai
Kleine-Tebbe, Jorg
Kouznetsov, Rostislav
Kowalski, Marek L.
Kritikos, Vicky
Kull, Inger
La Grutta, Stefania
Leonardini, Lisa
Ljungberg, Henrik
Lieberman, Philip
Lipworth, Brian
Lodrup Carlsen, Karin C.
Lopes-Pereira, Catarina
Loureiro, Claudia C.
Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Zuberbier T, Lotvall J, Simoens S, Subramanian SV, Church MK. Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review. Allergy 2014;69(10):1275-1279.
Gopal G, Suter-Crazzolara C, Toldo L, Eberhardt W. Digital transformation in healthcare—architectures of present and future information technologies. Clin Chem Lab Med. 2019;57(3):328-335.
Mesko B, Drobni Z, Benyei E, Gergely B, Gyorffy Z. Digital health is a cultural transformation of traditional healthcare. Mhealth. 2017;3:38.
Bousquet J, Chavannes NH, Guldemond N, Haahtela T, Hellings PW, Sheikh A. Realising the potential of mHealth to improve asthma and allergy care: how to shape the future. Eur Respir J. 2017;49(5): 1601966. https://doi.org/10.1183/13993003.01966-2016
Bousquet J, Ansotegui IJ, Anto JM, et al. Mobile technology in allergic rhinitis: evolution in management or revolution in health and care? J Allergy Clin Immunol Pract. 2019;7(8):2511-2533.
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European innovation partnership on active and healthy ageing: the European geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361-362.
Bousquet J, Addis A, Adcock I, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304-323.
Bousquet J, Barbara C, Bateman E, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028-1033.
Bousquet J, Anto JM, Bachert C, et al. From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity. Eur Respir J. 2019;54(6):1901023.
Nogueira-Silva L, Martins SV, Cruz-Correia R, et al. Control of allergic rhinitis and asthma test—a formal approach to the development of a measuring tool. Respir Res. 2009;10:52.
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl 86):8-160.
Bousquet J, Hellings PW, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019;143(3):864-879.
Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47.
Bousquet J, Bedbrook A, Czarlewski W, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9:16.
Courbis A-L, Murray RB, Arnavielhe S, et al. Electronic clinical decision support system for allergic rhinitis management: MASK e-CDSS. Clin Exp Allergy. 2018;48(12):1640-1653.
Bousquet J, Agache I, Aliberti MR, et al. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA)—EIP on AHA TWINNING Reference Site (GARD research demonstration project). Allergy 2018;73(1):77-92.
Bousquet J, Arnavielhe S, Bedbrook A, et al. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence. Clin Transl Allergy. 2018;8:45.
Bousquet J, Devillier P, Anto JM, et al. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy 2018;73(8):1622-1631.
Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: the MASK study. J Allergy Clin Immunol. 2019;144(1):135-143.e6.
Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy 2010;65(8):1042-1048.
van der Leeuw S, van der Molen T, Dekhuijzen PNR, et al. The minimal clinically important difference of the control of allergic rhinitis and asthma test (CARAT): cross-cultural validation and relation with pollen counts. NPJ Prim Care Respir Med. 2015;25:14107.
Azevedo P, Correia-de-Sousa J, Bousquet J, et al. Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care. Prim Care Respir J. 2013;22(1):112-116.
Bousquet J, Anto JM, Annesi-Maesano I, et al. POLLAR: impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy. 2018;8:36.
Bedard A, Anto JM, Fonseca JA, et al. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air((R)) App. Allergy 2020. https://doi.org/10.1111/all.14204. [Epub ahead of print].
Bousquet J, Farrell J, Crooks G, et al. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clin Transl Allergy. 2016;6:29.
Hellings PW, Muraro A, Fokkens W, et al. A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress. Clin Transl Allergy. 2015;5:36.
Klimek L, Bergmann K-C, Biedermann T, et al. Visual analogue scales (VAS): measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: position paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC). Allergo J Int. 2017;26(1):16-24.
Recital 26-EU GDPR. EU general data protection regulation 2016/679. 2016; https://doi.org/10.1111/all.14204 [Epub ahead of print]
Article 4 EU GDPR. EU general data protection regulation 2016/679 (GDPR). http://www.privacy-regulation.eu/en/article-4-definitions-GDPR.htm; 2016.
Laune D, Arnavielhe S, Viart F, et al. Application du Règlement Général sur la Protection des Données (RGPD) à une application mobile pour la rhinite et l'asthme (MASK-air). Rev Mal Resp. 2019;36(9):1019-1031.
Samreth D, Arnavielhe S, Ingenrieth F, et al. Geolocation with respect to personal privacy for the Allergy Diary app—a MASK study. World Allergy Organ J. 2018;11(1):15.
EU Medical Device regulation. 1/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. https://eur-lexeuropaeu/legal-content/EN/ALL/?uri=CELEX:32017R0745; 2017.
Caimmi D, Baiz N, Tanno LK, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017;47(12):1526-1533.
Bousquet J, Bewick M, Arnavielhe S, et al. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy 2017;72(10):1475-1484.
Bousquet J, Caimmi DP, Bedbrook A, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy 2017;72(6):857-865.
Bousquet J, Arnavielhe S, Bedbrook A, et al. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy 2018;73(2):505-510.
Bousquet J, Devillier P, Arnavielhe S, et al. Treatment of allergic rhinitis using mobile technology with real-world data: the MASK observational pilot study. Allergy 2018;73(9):1763-1774.
Bousquet J, VandenPlas O, Bewick M, et al. The Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) questionnaire using mobile technology: The MASK study. J Investig Allergol Clin Immunol. 2018;28(1):42-44.
Menditto E, Costa E, Midao L, et al. Adherence to treatment in allergic rhinitis using mobile technology. The MASK study. Clin Exp Allergy. 2019;49(4):442-460.
Bédard A, Sofiev M, Arnavielhe S, et al. Interactions between air pollution and pollen season for rhinitis using mobile technology: a MASK-POLLAR study. J Allergy Clin Immunol Pract. 2020;8(3):1063-1073.e4.
Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3.
Lourenco O, Calado S, Sa-Sousa A, Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Manag Care Spec Pharm. 2014;20(5):513-522.
Amaral L, Martins C, Coimbra A. Use of the Control of Allergic Rhinitis and Asthma Test and pulmonary function tests to assess asthma control in pregnancy. Aust N Z J Obstet Gynaecol. 2018;58(1):86-90.
Kuipers E, Wensing M, de Smet P, Teichert M. Self-management research of asthma and good drug use (SMARAGD study): a pilot trial. Int J Clin Pharm. 2017;39(4):888-896.
Sá-Sousa A, Amaral R, Morais-Almeida M, et al. Asthma control in the Portuguese National Asthma Survey. Rev Port Pneumol 2006;2015(21):209-213.
Component Resolved Diagnostics (CRD) and mHealth for Pollen Allergy in Southern Europe. (IT-2020-MC). https://clinicaltrials.gov/ct2/show/NCT03636919); 2020.
Flokstra-de-Blok B, Baretta H, Fonseca J, et al. An app to measure and improve adherence to inhaled treatment. Proc Int Conf e-Health. 2017;2017:135-139.
Kosse RC, Bouvy ML, de Vries TW, et al. mHealth intervention to support asthma self-management in adolescents: the ADAPT study. Patient Prefer Adherence. 2017;11:571-577.
Flokstra-de Blok BMJ, Baretta H-J, Fonseca JA, et al. Control of Allergic Rhinitis and Asthma Test with 1-week recall: validation of paper and electronic version. Allergy 2018;73(12):2381-2385.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol. 2010;63(7):737-745.
Burnay E, Cruz-Correia R, Jacinto T, Sousa AS, Fonseca J. Challenges of a mobile application for asthma and allergic rhinitis patient enablement-interface and synchronization. Telemed J E Health. 2013;19(1):13-18.
Kosse RC, Bouvy ML, Belitser SV, de Vries TW, van der Wal PS, Koster ES. Effective engagement of adolescent asthma patients with mobile health-supporting medication adherence. JMIR mHealth uHealth. 2019;7(3):e12411.
Gani F, Lombardi C, Barrocu L, et al. The control of allergic rhinitis in real life: a multicenter cross-sectional Italian study. Clin Mol Allergy. 2018;16:4.
Sousa AS, Pereira AM, Fonseca JA, et al. Asthma control and exacerbations in patients with severe asthma treated with omalizumab in Portugal. Rev Port Pneumol (2006). 2015:pii:S2173-5115(15)00080-9
Bousquet J, Schunemann HJ, Hellings PW, et al. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis. J Allergy Clin Immunol. 2016;138(2):367–374.e2.
Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2019.
Sofiev M, Vira J, Kouznetsov R, Prank M, Soares J, Genikhovich E. Construction of the SILAM Eulerian atmospheric dispersion model based on the advection algorithm of Michael Galperin. Geosci Model Dev 2015;8(11):3497-3522.
Sofiev M. On impact of transport conditions on variability of the seasonal pollen index. Aerobiologia (Bologna). 2017;33(1):167-179.
Ritenberga O, Sofiev M, Siljamo P, et al. A statistical model for predicting the inter-annual variability of birch pollen abundance in Northern and North-Eastern Europe. Sci Total Environ. 2018;615:228-239.
Amaral R, Bousquet J, Pereira AM, et al. Disentangling the heterogeneity of allergic respiratory diseases by latent class analysis reveals novel phenotypes. Allergy 2019;74(4):698-708.
Raciborski F, Bousquet J, Namysłowski A, et al. Correction to: Dissociating polysensitization and multimorbidity in children and adults from a Polish general population cohort. Clin Transl Allergy. 2019;9:23.
Siroux V, Boudier A, Nadif R, Lupinek C, Valenta R, Bousquet J. Association between asthma, rhinitis, and conjunctivitis multimorbidities with molecular IgE sensitization in adults. Allergy 2019;74(4):824-827.
Toppila-Salmi S, Chanoine S, Karjalainen J, Pekkanen J, Bousquet J, Siroux V. Risk of adult-onset asthma increases with the number of allergic multimorbidities and decreases with age. Allergy. 2019;74(12):2406-2416.
Bousquet J, Meltzer EO, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726-1732.
Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity. A systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274-1286.e9.
Bosnic-Anticevich S, Costa E, Menditto E, et al. ARIA pharmacy 2018 “Allergic rhinitis care pathways for community pharmacy”: AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project. Allergy 2019;74(7):1219-1236.
Bousquet J, Pfaar O, Togias A, et al. 2019 ARIA Care pathways for allergen immunotherapy. Allergy 2019;74(11):2087-2102.
Bousquet JJ, Schünemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44.
Patella V, Florio G, Magliacane D, et al. Prevention Plans to manage climate change and respiratory allergic diseases. Innovative models used in Campania Region (Italy): the TWINNING aria implementation and the allergy safe tree decalogue. Transl Med UniSa. 2019;19:95-102.
Poole CD, Bannister CA, Andreasen JN, Andersen JS, Currie CJ. Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health Qual Life Outcomes. 2014;12:99.
Soler R, de la Hoz B, Badia X, et al. Validation of the Spanish version of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Rev Clin Esp. 2004;204(3):131-138.
Hoehle LP, Speth MM, Phillips KM, et al. Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy. 2017;31(4):235-239.
Hwang TY, Kim SK, Kim SH, Kim M. A cross sectional survey on health-related quality of life among parents of children with allergic symptoms using the EQ-5D-5L. J Asthma. 2019;56(11):1-7.
Ilyina N, Edin A, Astafieva N, et al. Efficacy of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, delivered in a single spray, for the treatment of seasonal Allergic Rhinitis: results from Russia. Int Arch Allergy Immunol. 2019;178(3):255-263.
Speth MM, Hoehle LP, Phillips KM, Caradonna DS, Gray ST, Sedaghat AR. Treatment history and association between allergic rhinitis symptoms and quality of life. Ir J Med Sci. 2019;188(2):703-710.
Bousquet J, Pham-Thi N, Bedbrook A, et al. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 1). J Thorac Dis. 2019;11(8):3633-3642.
Bousquet J, Pham-Thi N, Bedbrook A, et al. Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases-Meeting Report (Part 2). J Thorac Dis. 2019;11(9):4072-4084.
Brożek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476.
Brożek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines—2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958.
Wallace DV, Dykewicz MS, Oppenheimer J, Portnoy JM, Lang DM. Pharmacologic treatment of seasonal Allergic Rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters. Ann Intern Med. 2017;177(12):876-881.
Bousquet J, Schünemann H, Togias A, et al. Next-generation ARIA guidelines for allergic rhinitis based on GRADE and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. https://doi.org/10.1016/j.jaci.2019.06.049. Epub 2019 Oct 15.
Calderon MA, Demoly P, Casale T, et al. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Clin Transl Allergy. 2016;6:41.
Wallace DV, Dykewicz MS. Seasonal Allergic Rhinitis: a focused systematic review and practice parameter update. Curr Opin Allergy Clin Immunol. 2017;17(4):286-294.
Patel P, Salapatek AM, Tantry SK. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol. 2019;122(2):160-166.e1.
Bousquet J, Burney PG, Zuberbier T, et al. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma ‘epidemic’. Allergy 2009;64(7):969-977.
Maurer M, Metz M, Bindslev-Jensen C, et al. Definition, aims, and implementation of GA(2)LEN Urticaria Centers of reference and excellence. Allergy 2016;71:1210-1218.
Godicke V, Hundt F. Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline. Allergy 2010;65(12):1499-1505.
Pfaar O, Demoly P, Gerth van Wijk R, et al. Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. Allergy 2014;69(7):854-867.
Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy 2017;72(8):1156-1173.
Whitmee S, Haines A, Beyrer C, et al. Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health. Lancet 2015;386(10007):1973-2028.
Konduri N, Aboagye-Nyame F, Mabirizi D, et al. Digital health technologies to support access to medicines and pharmaceutical services in the achievement of sustainable development goals. Digit Health. 2018;4:2055207618771407.
Toumi M, Remuzat C. Value added medicines: what value repurposed medicines might bring to society? J Mark Access Health Policy. 2017;5(1):1264717.
Bachert C, Bousquet J, Hellings P. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management. Clin Transl Allergy. 2018;8:25.
Bousquet J, Illario M, Farrell J, et al. The reference site collaborative network of the European innovation partnership on active and healthy ageing. Transl Med UniSa. 2019;19:66-81.
Samolinski B, Fronczak A, Wlodarczyk A, Bousquet J. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet 2012;379(9822):e45-e46.
Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007;62(3):216-223.
Global Alliance against Chronic Respiratory Diseases (GARD). 9th General Meeting, 14–16 August 2014, Salvador, Brazil. WHO/NMH/MND/CPM/14.1. www.who.int. 2014.
Hellings PW, Fokkens WJ, Bachert C, et al. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - a EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy 2017;72(9):1297-1305.
Hellings PW, Borrelli D, Pietikainen S, et al. European summit on the prevention and self-management of chronic respiratory diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2017;7:49.
Muraro A, Fokkens WJ, Pietikainen S, et al. European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015). Rhinology. 2015;53(4):303-307.
Valiulis A, Bousquet J, Veryga A, et al. Vilnius declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases. Clin Transl Allergy. 2019;9:7.
Kotter J. Leading change. Boston, MA: Harvard Business School Press; 1996.
Ozdalga E, Ozdalga A, Ahuja N. The smartphone in medicine: a review of current and potential use among physicians and students. J Med Internet Res. 2012;14(5):e128.
Bousquet J, Anto JM, Haahtela T, Jousilahti P, Erhola M, Basagana X, et al. Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland’s Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respiratory Diseases (GARD, WHO), demonstration project, Reference Site Collaborative Network of the European Innovation Partnership on Active and Healthy Ageing. Clin Transl Allergy. 2020;10:24.
